Risk of Ocular Hypertension With Intravitreal Triamcinolone Compared to the Dexamethasone Implant. [PDF]
Chebolu AP +3 more
europepmc +1 more source
Compliance to intravitreal anti-vascular endothelial growth factors for treatment of retinal diseases in Nigerians: a retrospective multicenter study. [PDF]
Okonkwo ON +5 more
europepmc +1 more source
Long-term analysis of intravitreal brolucizumab in recalcitrant cases of chronic central serous retinopathy complicated by neovascularization (pachychoroid neovasculopathy). [PDF]
Verma L +9 more
europepmc +1 more source
Effect of intravitreal injection of dexamethasone implant on the corneal morphology of young adults with central retinal vein occlusion. [PDF]
Niu TT, Xin WJ.
europepmc +1 more source
Long term evaluation of the safety and efficacy of local cooling anesthesia during intravitreal injections: The COOL-2 Trial. [PDF]
Khanani AM +4 more
europepmc +1 more source
Nationwide trends and regional variation in intravitreal injections and anti-VEGF agent use in Japan from 2017 to 2022: An analysis of the NDB Open Data. [PDF]
Kabata Y, Terauchi R, Nakano T.
europepmc +1 more source
Computational modeling of intravitreal ranibizumab kinetics: Predicting macular drug concentration and half-life. [PDF]
Chowdhury JM.
europepmc +1 more source
Current role of aflibercept in retinopathy of prematurity - A review. [PDF]
Kumawat D, Shaikh N, Chandra P.
europepmc +1 more source

